SARGENOR 1 g/5 ml, oral solution 20 ampoules of 5 ml
Active ingredients: Arginine aspartate
Commercialized according to BDPM
Oral solution20 ampoules of 5 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SARGENOR 1 g/5 ml, solution buvable
- Pharmaceutical form
- solution buvable
- Route of administration
- orale
- Presentation description
- 20 ampoule(s) en verre brun de 5 ml
- Marketing authorisation holder
- COOPER (ABRÉGÉ DE COOPERATION PHARMACEUTIQUE FRANCAISE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 Feb 2024
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64556465CIP73289283CIP133400932892839Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ARGININE (ASPARTATE D')solution | 1,000 g · une ampoule de 5 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.